These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20487615)

  • 21. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.
    Ahmad S; Mokaddas E
    Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberculosis drug resistance and treatment outcomes under DOTS settings in large cities in the Philippines.
    Ohkado A; Aguiman L; Adlawan S; Baring E; Quirante O; Suchi M; Endo S; Fujiki A; Mori T
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):283-9. PubMed ID: 16562708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.
    Laserson KF; Thorpe LE; Leimane V; Weyer K; Mitnick CD; Riekstina V; Zarovska E; Rich ML; Fraser HS; Alarcón E; Cegielski JP; Grzemska M; Gupta R; Espinal M
    Int J Tuberc Lung Dis; 2005 Jun; 9(6):640-5. PubMed ID: 15971391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001-2003.
    Anuradha B; Aparna S; Hari Sai Priya V; Vijaya Lakshmi V; Akbar Y; Suman Latha G; Murthy KJ
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):58-62. PubMed ID: 16466038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding.
    Caminero JA
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):382-90. PubMed ID: 20202293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Emergence extensive drug resistance tuberculosis (XDR)].
    Vier H; Schaberg T; Gillissen A
    Pneumologie; 2007 Sep; 61(9):606-9. PubMed ID: 17729211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Programmatic management of multidrug resistant TB.
    Sarin R
    Indian J Tuberc; 2009 Oct; 56(4):171-3. PubMed ID: 20469727
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of multi-drug resistant tuberculosis: practitioner's view point.
    Prasad R
    Indian J Tuberc; 2007 Jan; 54(1):3-11. PubMed ID: 17455417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of multi drug resistance tuberculosis in the field: Tuberculosis Research Centre experience.
    Thomas A; Ramachandran R; Rehaman F; Jaggarajamma K; Santha T; Selvakumar N; Krishnan N; Mohan NS; Sundaram V; Wares F; Narayanan PR
    Indian J Tuberc; 2007 Jul; 54(3):117-24. PubMed ID: 17886699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-resistant tuberculosis in Ethiopia: problem scenarios and recommendation.
    Abate G
    Ethiop Med J; 2002 Jan; 40(1):79-86. PubMed ID: 12240570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of multidrug-resistant tuberculosis strains in patients from private and public health care facilities in Nairobi, Kenya.
    Githui WA; Meme HK; Juma ES; Kinyanjui P; Karimi F; Chakaya JM; Kangangi J; Kutwa A
    Int J Tuberc Lung Dis; 2004 Jul; 8(7):837-41. PubMed ID: 15260274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis.
    Villarino ME; Geiter LJ; Simone PM
    Public Health Rep; 1992; 107(6):616-25. PubMed ID: 1454973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the nurse in the community-based treatment of multidrug-resistant tuberculosis (MDR-TB).
    Palacios E; Guerra D; Llaro K; Chalco K; Sapag R; Furin J
    Int J Tuberc Lung Dis; 2003 Apr; 7(4):343-6. PubMed ID: 12729339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB.
    Kimerling ME; Kluge H; Vezhnina N; Iacovazzi T; Demeulenaere T; Portaels F; Matthys F
    Int J Tuberc Lung Dis; 1999 May; 3(5):451-3. PubMed ID: 10331736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Programmatic management of multidrug-resistant tuberculosis: models from three countries.
    Furin J; Bayona J; Becerra M; Farmer P; Golubkov A; Hurtado R; Joseph JK; Keshavjee S; Ponomarenko O; Rich M; Shin S
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1294-300. PubMed ID: 21669029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beyond DOtS: avenues ahead in the management of tuberculosis.
    Chaudhury RR; Thatte U
    Natl Med J India; 2003; 16(6):321-7. PubMed ID: 14765625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation.
    Caminero JA
    Int J Tuberc Lung Dis; 2008 Aug; 12(8):869-77. PubMed ID: 18647445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia.
    Jugheli L; Rigouts L; Shamputa IC; Bram de Rijk W; Portaels F
    Int J Tuberc Lung Dis; 2008 May; 12(5):561-6. PubMed ID: 18419893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.